BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29666945)

  • 1. Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival.
    Kim JY; Lee SH; An S; Kim SJ; Sung YN; Song KB; Hwang DW; Kim SC; Hong SM
    Virchows Arch; 2018 May; 472(5):739-748. PubMed ID: 29666945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival.
    Kim JY; Brosnan-Cashman JA; An S; Kim SJ; Song KB; Kim MS; Kim MJ; Hwang DW; Meeker AK; Yu E; Kim SC; Hruban RH; Heaphy CM; Hong SM
    Clin Cancer Res; 2017 Mar; 23(6):1598-1606. PubMed ID: 27663587
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinicopathologic and prognostic significance of multiple hormone expression in pancreatic neuroendocrine tumors.
    Kim JY; Kim MS; Kim KS; Song KB; Lee SH; Hwang DW; Kim KP; Kim HJ; Yu E; Kim SC; Jang HJ; Hong SM
    Am J Surg Pathol; 2015 May; 39(5):592-601. PubMed ID: 25602797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of carbonic anhydrase 9 is a novel prognostic marker in resectable hepatocellular carcinoma.
    Kang HJ; Kim IH; Sung CO; Shim JH; Yu E
    Virchows Arch; 2015 Apr; 466(4):403-13. PubMed ID: 25577552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA9 overexpression is an independent favorable prognostic marker in intrahepatic cholangiocarcinoma.
    Gu M
    Int J Clin Exp Pathol; 2015; 8(1):862-6. PubMed ID: 25755787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1α, CXCR4 and CA9 in colorectal carcinoma.
    Saka B; Ekinci O; Dursun A; Akyurek N
    Pathol Res Pract; 2017 Jul; 213(7):783-792. PubMed ID: 28554753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of FZD1 and CAIX are Associated with Invasion, Metastasis, and Poor-Prognosis of the Pancreatic Ductal Adenocarcinoma.
    Yang L; Yang Z; Li D; Liu Z; Zou Q; Yuan Y; Xu H
    Pathol Oncol Res; 2018 Oct; 24(4):899-906. PubMed ID: 28921449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
    Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS
    Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors.
    Chou A; Itchins M; de Reuver PR; Arena J; Clarkson A; Sheen A; Sioson L; Cheung V; Perren A; Nahm C; Mittal A; Samra JS; Pajic M; Gill AJ
    Hum Pathol; 2018 Dec; 82():249-257. PubMed ID: 30081149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of carbonic anhydrase IX is associated with poor prognosis through regulation of the epithelial‑mesenchymal transition in hepatocellular carcinoma.
    Hyuga S; Wada H; Eguchi H; Otsuru T; Iwgami Y; Yamada D; Noda T; Asaoka T; Kawamoto K; Gotoh K; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
    Int J Oncol; 2017 Oct; 51(4):1179-1190. PubMed ID: 28849188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme.
    Cetin B; Gonul II; Gumusay O; Bilgetekin I; Algin E; Ozet A; Uner A
    Neuropathology; 2018 Oct; 38(5):457-462. PubMed ID: 29952031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expressions of carbonic anhydrase 9 and vascular endothelial growth factor in astrocytic tumors predict a poor prognosis.
    Yoo H; Sohn S; Nam BH; Min HS; Jung E; Shin SH; Gwak HS; Lee SH
    Int J Mol Med; 2010 Jul; 26(1):3-9. PubMed ID: 20514415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133 expression in well-differentiated pancreatic neuroendocrine tumors: a potential predictor of progressive clinical courses.
    Sakai Y; Hong SM; An S; Kim JY; Corbeil D; Karbanová J; Otani K; Fujikura K; Song KB; Kim SC; Akita M; Nanno Y; Toyama H; Fukumoto T; Ku Y; Hirose T; Itoh T; Zen Y
    Hum Pathol; 2017 Mar; 61():148-157. PubMed ID: 27864124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase IX expression is associated with favorable prognostic factors in small intestinal carcinoma.
    Gu MJ; Kwon KW
    J Histochem Cytochem; 2014 Mar; 62(3):205-10. PubMed ID: 24217923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD47 expression and CD163
    Imam R; Chang Q; Black M; Yu C; Cao W
    BMC Cancer; 2021 Mar; 21(1):320. PubMed ID: 33765961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment.
    Ibis K; Saglam S; Saglam EK; Firat P; Yilmazbayhan D; Toker A; Ozkan B; Hancer VS; Buyukdogan M; Disci R; Pilanci KN
    Pathol Res Pract; 2018 Sep; 214(9):1291-1296. PubMed ID: 30029935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of microvessel density and carbonic anhydrase-9 (CA-9) expression in rectal cancer.
    Rasheed S; Harris AL; Tekkis PP; Turley H; Silver A; McDonald PJ; Talbot IC; Glynne-Jones R; Northover JM; Guenther T
    Pathol Res Pract; 2009; 205(1):1-9. PubMed ID: 19008051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic acinar cell carcinomas and mixed acinar-neuroendocrine carcinomas are more clinically aggressive than grade 1 pancreatic neuroendocrine tumours.
    Kim JY; Brosnan-Cashman JA; Kim J; An S; Lee KB; Kim H; Park DY; Jang KT; Oh YH; Hruban RH; Heaphy CM; Hong SM
    Pathology; 2020 Apr; 52(3):336-347. PubMed ID: 32111396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of the hypoxia markers CA9 and CXCR4 is correlated with survival in patients with neuroendocrine tumours of the ileum.
    Deschamps L; Bacha D; Rebours V; Mebarki M; Bretagnol F; Panis Y; Bedossa P; Ruszniewski P; Couvelard A
    Neuroendocrinology; 2012; 95(3):214-22. PubMed ID: 22133596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Progesterone Receptor Expression Is an Early Tumorigenesis Event Associated with Tumor Progression and Shorter Survival in Pancreatic Neuroendocrine Tumor Patients.
    Kim SJ; An S; Lee JH; Kim JY; Song KB; Hwang DW; Kim SC; Yu E; Hong SM
    J Pathol Transl Med; 2017 Jul; 51(4):388-395. PubMed ID: 28597868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.